SFX by Ex Libris Inc.

Title:	Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells
Source:	Blood [0006-4971] Suryani, Santi yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Grossman, William J J. "Human T regulatory cells can use the perforin pathway to cause autologous target cell death." Immunity 21.4 (2004): 589-601.
description	2.	Vousden, Karen H H. "p53 in health and disease." Nature reviews. Molecular cell biology 8.4 (2007): 275-83.
description	3.	Wardemann, H. "Predominant autoantibody production by early human B cell precursors." Science 301.5638 (2003): 1374-7.
description	4.	Cao, X. "Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance." Immunity 27.4 (2007): 635-46.
description	5.	Deusch, E. "The effects of high molecular weight hydroxyethyl starch solutions on platelets." Anesthesia and analgesia 99.3 (2004): 665-8.
description	6.	Kastan, Michael B B. "Wild-type p53: tumors can't stand it." Cell 128.5 (2007): 837-40.
description	7.	Skoien, JO, Y. "Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells." Nature medicine 14.2 (2008): 162-9.
description	8.	Gondek, David C C. "Cutting edge: contact-mediated suppression by CD4࠽ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism." The journal of immunology 174.4 (2005): 1783-6.
description	9.	Shresta, S. "Granzyme A initiates an alternative pathway for granule-mediated apoptosis." Immunity 10.5 (1999): 595-605.
description	10.	Huang, Ching-Tai T. "Role of LAG-3 in regulatory T cells." Immunity 21.4 (2004): 503-13.
description	11.	Taniguchi, M. "The regulatory role of Valpha14 NKT cells in innate and acquired immune response." Annual review of immunology 21 (2003): 483-513.
description	12.	Cambier, J. "B-cell anergy: from transgenic models to naturally occurring anergic B cells?" Nature reviews. Immunology 7.8 (2007): 633-643.
description	13.	Toledo, F. "Regulating the p53 pathway: in vitro hypotheses, in vivo veritas." Nature reviews. Cancer 6.12 (2007): 909-23.
description	14.	Royds, J A A. "p53 and disease: when the guardian angel fails." Cell death and differentiation 13.6 (2006): 1017-26.
description	15.	Laptenko, O. "Transcriptional regulation by p53: one protein, many possibilities." Cell death and differentiation 13.6 (2006): 951-61.
description	16.	Vogelstein, Bert, B. "Surfing the p53 network." Nature 408.6810 (2000): 307-10.
description	17.	Connolly, H G G. "Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1." Cardiovascular & hematological agents in medicinal chemistry 1.1 (2003): 47-59.
description	18.	Boldt, J. "New light on intravascular volume replacement regimens: what did we learn from the past three years?" Anesthesia and analgesia 97.6 (2004): 1595-1604.
description	19.	Zuniga-Pflucker, Juan C. "CD8+ T cells are kept in tune by modulating IL-7 responsiveness." Nature immunology 8.10 (2007): 1027-1028.
description	20.	Nowacki, Tobias M M. "Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells." Cellular immunology 247.1 (2007): 36-48.